Coston McIsaac & Partners’s Zimmer Biomet ZBH Stock Holding History

Coston McIsaac & Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8K	Sell	94 -30	-24%	-$2.63K	﹤0.01%	622
2026 Q1	$11K	Hold	124	–	–	﹤0.01%	567
2025 Q4	$11K	Hold	124	–	–	﹤0.01%	568
2025 Q3	$12K	Hold	124	–	–	﹤0.01%	525
2025 Q2	$11K	Hold	124	–	–	﹤0.01%	516
2025 Q1	$14K	Hold	124	–	–	﹤0.01%	457
2024 Q4	$13K	Hold	124	–	–	﹤0.01%	456
2024 Q3	$13	Hold	124	–	–	﹤0.01%	460
2024 Q2	$13K	Hold	124	–	–	﹤0.01%	438
2024 Q1	$16K	Hold	124	–	–	0.01%	414
2023 Q4	$15K	Hold	124	–	–	0.01%	430
2023 Q3	$13K	Sell	124 -32	-21%	-$4.06K	﹤0.01%	446
2023 Q2	$22K	Hold	156	–	–	0.01%	394
2023 Q1	$20K	Hold	156	–	–	0.01%	399
2022 Q4	$19	Hold	156	–	–	0.01%	408
2022 Q3	$16K	Sell	156 -1	-0.6%	-$110	0.01%	363
2022 Q2	$16K	Buy	+157	New	+$18.6K	0.01%	237

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Coston McIsaac & Partners's ZBH Position: Q2 2026 in Review

Coston McIsaac & Partners reduced its Zimmer Biomet (ZBH) stake by 24% in Q2 2026, selling an estimated $2.63K and leaving 94 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #622.

Coston McIsaac & Partners first reported a position in ZBH in Q2 2022 and has held it in 17 quarters since. The position peaked at $22K in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Coston McIsaac & Partners held 94 shares of Zimmer Biomet worth $8K as of Q2 2026.
Coston McIsaac & Partners sold 30 Zimmer Biomet shares in Q2 2026, an estimated $2.63K.
Zimmer Biomet made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #622 holding.
Coston McIsaac & Partners first reported a position in Zimmer Biomet in Q2 2022 and has held it in 17 quarters since.
Coston McIsaac & Partners's Zimmer Biomet position peaked at $22K in Q2 2023.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.